Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
Clinical Immunology

Antigen-Specific Memory T Cell Responses after Vaccination with an Oral Killed Cholera Vaccine in Bangladeshi Children and Comparison to Responses in Patients with Naturally Acquired Cholera

Mohammad Arifuzzaman, Rasheduzzaman Rashu, Daniel T. Leung, M. Ismail Hosen, Taufiqur Rahman Bhuiyan, M. Saruar Bhuiyan, Mohammad Arif Rahman, Farhana Khanam, Amit Saha, Richelle C. Charles, Regina C. LaRocque, Ana A. Weil, John D. Clements, Randall K. Holmes, Stephen B. Calderwood, Jason B. Harris, Edward T. Ryan, Firdausi Qadri
Mohammad Arifuzzaman
aCentre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
bDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rasheduzzaman Rashu
aCentre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel T. Leung
aCentre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
bDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
cDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Ismail Hosen
aCentre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taufiqur Rahman Bhuiyan
aCentre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Saruar Bhuiyan
aCentre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad Arif Rahman
aCentre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farhana Khanam
aCentre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amit Saha
aCentre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richelle C. Charles
bDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
cDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Regina C. LaRocque
bDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
cDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana A. Weil
bDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John D. Clements
dDepartment of Microbiology and Immunology, Tulane University Medical Center, New Orleans, Louisiana, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Randall K. Holmes
eDepartment of Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen B. Calderwood
bDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
cDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA
fDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason B. Harris
bDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
gDepartment of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward T. Ryan
bDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
cDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA
hDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Firdausi Qadri
aCentre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/CVI.00196-12
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Fig 1
    • Open in new tab
    • Download powerpoint
    Fig 1

    Time line for vaccination, blood draws, and immunological assays. For vaccinees, d21 and d42 indicate 7 days and 4 weeks from the second dose of vaccine, respectively. For patients, d2 indicates the acute stage of infection; d7 and d30 indicate the early and late convalescent phases, respectively. (d, day; MBC, memory B cell).

  • Fig 2
    • Open in new tab
    • Download powerpoint
    Fig 2

    Comparison of different toxin derivatives as T cell stimulatory antigens. Stimulation indices of patients (n = 9) at different time points are shown, with horizontal bars representing median stimulation indices. The toxin antigens include the following: recombinant cholera toxin B subunit (rCTB) (a gift from AM Svennerholm), the G33D variant of CTB (mCTB) (48), native CT, G33D variant of CT holotoxin (mCT) (48), double mutant LT (dmLT) (30), and membrane preparation of V. cholerae O1 (MP).

  • Fig 3
    • Open in new tab
    • Download powerpoint
    Fig 3

    Comparison of different toxin derivatives as T cell stimulatory antigens in younger children receiving vaccine (n = 20), older children receiving vaccine (n = 20), and patients with naturally acquired cholera (n = 8). Mean stimulation indexes of T effector memory cells and their subtypes, with error bars representing standard errors of the means, are given. An asterisk (*) denotes a significant difference (P ≤ 0.05) from the baseline (day 2 for patients and day 0 for vaccinees). “∧” indicates a significant increase (P ≤ 0.05) in responses on day 7 for patients compared to day 21 responses in older vaccinees. The G33D variant of CT holotoxin (mCT), membrane preparation of V. cholerae O1 (MP), T effector memory cells (TEM), and T follicular helper cells (TFH) are analyzed.

  • Fig 4
    • Open in new tab
    • Download powerpoint
    Fig 4

    Correlation between cholera toxin-specific early T cell responses and later B cell memory responses. Percentages of rCTB-specific IgG memory B cells in older vaccinees (n = 9) on day 42 correlated with stimulation indices of G33D variant of CT holotoxin (mCT) specific T effector memory (TEM) cells on day 21.

  • Fig 5
    • Open in new tab
    • Download powerpoint
    Fig 5

    Cytokines in cell culture supernatants of older (n = 20) and younger (n = 20) children receiving vaccine and patients (n = 6) stimulated with mCT. Cytokine concentrations at different time points are shown for each vaccinee and patient, with horizontal bars representing medians. A single asterisk (*) indicates P ≤ 0.05, and double asterisks (**) indicate P ≤ 0.01 for later time points compared to earlier time points. Cytokines were measured 7 days after the second dose of vaccine on day 14 (i.e., on day 21) or 7 days after presenting for care for naturally acquired cholera (day 7).

Additional Files

  • Figures
  • Supplemental material

    Files in this Data Supplement:

    • Supplemental file 1 -

      Fig. S1. Dead cells after 6 days of ex vivo whole blood stimulation. Fig. S2a. Analysis of cells from a lymphoblast population with (A) or without (B) doublets. Fig. S2b. Gating strategy.

      PDF, 201K

PreviousNext
Back to top
Download PDF
Citation Tools
Antigen-Specific Memory T Cell Responses after Vaccination with an Oral Killed Cholera Vaccine in Bangladeshi Children and Comparison to Responses in Patients with Naturally Acquired Cholera
Mohammad Arifuzzaman, Rasheduzzaman Rashu, Daniel T. Leung, M. Ismail Hosen, Taufiqur Rahman Bhuiyan, M. Saruar Bhuiyan, Mohammad Arif Rahman, Farhana Khanam, Amit Saha, Richelle C. Charles, Regina C. LaRocque, Ana A. Weil, John D. Clements, Randall K. Holmes, Stephen B. Calderwood, Jason B. Harris, Edward T. Ryan, Firdausi Qadri
Clinical and Vaccine Immunology Jul 2012, 19 (8) 1304-1311; DOI: 10.1128/CVI.00196-12

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Clinical and Vaccine Immunology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antigen-Specific Memory T Cell Responses after Vaccination with an Oral Killed Cholera Vaccine in Bangladeshi Children and Comparison to Responses in Patients with Naturally Acquired Cholera
(Your Name) has forwarded a page to you from Clinical and Vaccine Immunology
(Your Name) thought you would be interested in this article in Clinical and Vaccine Immunology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Antigen-Specific Memory T Cell Responses after Vaccination with an Oral Killed Cholera Vaccine in Bangladeshi Children and Comparison to Responses in Patients with Naturally Acquired Cholera
Mohammad Arifuzzaman, Rasheduzzaman Rashu, Daniel T. Leung, M. Ismail Hosen, Taufiqur Rahman Bhuiyan, M. Saruar Bhuiyan, Mohammad Arif Rahman, Farhana Khanam, Amit Saha, Richelle C. Charles, Regina C. LaRocque, Ana A. Weil, John D. Clements, Randall K. Holmes, Stephen B. Calderwood, Jason B. Harris, Edward T. Ryan, Firdausi Qadri
Clinical and Vaccine Immunology Jul 2012, 19 (8) 1304-1311; DOI: 10.1128/CVI.00196-12
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X